Home / Inspections / 1175325

FDA Inspection 1175325 — Aspire Fertility Institute McAllen

Aspire Fertility Institute McAllen — FEI 3013225167

The FDA completed an inspection of Aspire Fertility Institute McAllen on July 12, 2022 in Mcallen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 12, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mcallen, TX (United States)

Facility

Other inspections at this facility

  • 1277627 (NAI Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1076436 (NAI Mon Dec 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources